SEATTLE — NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a Class III Medical Device License from Health Canada, clearing the company to market its Prosigna® Breast Cancer Prognostic Gene Signature Assay for assessing a woman’s 10-year risk of distant […]
GERMANTOWN, Maryland, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its artus C. difficile QS-RGQ MDx Kit has been cleared by the U.S. Food and Drug Administration to qualitatively detect Clostridium difficile, a widespread healthcare-associated infection (HAI). In addition, the FDA has granted 510(k) regulatory clearance for the […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) announced it will unveil its new sample-to-answer system for infectious disease testing, ARIES™ at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). ARIES’ scalable throughput, easy to use design, and networked data management software will deliver rapid results with a simple workflow. The five assay launch […]
GLOSTRUP, Denmark — Dako, an Agilent Technologies company and worldwide provider of cancer diagnostic solutions, today announced the addition of two new antibodies, Anti-CK 8/18 and Anti-TdT, to the Dako portfolio of high-quality reagents, instruments and software. Anti-CK 8/18 is the first rabbit monoclonal antibody cocktail for cytokeratin 8/18 (CK 8/18) available from a major […]
Cambridge, UK.– Cambridge based Congenica Ltd, a clinical genome diagnostics and discovery company, announced today that it has been one of several Small Business Research Initiative competition awards funded by the UK Department of Health and managed by Genomics England. This funding will be used by Congenica to further develop it’s SAPIENTIATM platform that provides […]
LEXINGTON, Mass.–- N-of-One, Inc., the leading provider of clinical interpretation in oncology, today announced that the company is providing Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute in Los Angeles with database services for next-generation sequencing. “We are pleased to provide a database of genetic information to the team of physicians and scientists at Cedars-Sinai and to […]
SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of veteran diagnostics executive Tina S. Nova, Ph.D. to its Board of Directors. Dr. Nova will also join the Board’s Compensation Committee. “Dr. Tina Nova is a seasoned executive who successfully built […]
Victoria, B.C. — GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) specifically designed for omics labs, announced today that the 3.0 release of Clarity LIMS further supports the growing needs of genomics labs working in clinical environments, including those that are HIPAA-covered entities. This version includes cloud-based features that ensure […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the launch of VeriSeqTM PGS, a next-generation sequencing (NGS) solution developed for preimplantation genetic screening (PGS) of embryos using Illumina’s NextSeqTM 500 and MiSeq® sequencing systems. The offering brings together the industry-leading Illumina 24sure array-based platform for PGS with Illumina’s next-generation sequencing (NGS) technology to offer laboratories […]
Oxford Gene Technology (OGT), The Molecular Genetics Company, will launch its new SureSeq™ Solid Tumour Panel at the Association for Clinical Genetic Science (ACGS) meeting at Birmingham UK, on the 29-30th April. Fully validated on formalin-fixed, paraffin-embedded (FFPE) samples, the new 60-gene next generation sequencing (NGS) hybridisation-based enrichment panel offers researchers accurate and reliable solid […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
